These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Results of radiation therapy for medulloblastoma]. Shibamoto Y; Abe M; Tsutsui K; Ono K; Takahashi M Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2491-8. PubMed ID: 2614186 [TBL] [Abstract][Full Text] [Related]
3. Low-dose craniospinal radiation therapy for medulloblastoma. Halberg FE; Wara WM; Fippin LF; Edwards MS; Levin VA; Davis RL; Prados MB; Wilson CB Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):651-4. PubMed ID: 2004939 [TBL] [Abstract][Full Text] [Related]
4. Treatment of medulloblastoma with procarbazine, hydroxyurea, and reduced radiation doses to whole brain and spine. Levin VA; Rodriguez LA; Edwards MS; Wara W; Liu HC; Fulton D; Davis RL; Wilson CB; Silver P J Neurosurg; 1988 Mar; 68(3):383-7. PubMed ID: 3343610 [TBL] [Abstract][Full Text] [Related]
5. Longterm treatment results of childhood medulloblastoma by craniospinal irradiation in supine position. Slampa P; Pavelka Z; Dusek L; Hynkova L; Sterba J; Ondrova B; Princ D; Novotny T; Kostakova S Neoplasma; 2007; 54(1):62-7. PubMed ID: 17203894 [TBL] [Abstract][Full Text] [Related]
6. Patterns of failure following treatment for medulloblastoma: is it necessary to treat the entire posterior fossa? Fukunaga-Johnson N; Lee JH; Sandler HM; Robertson P; McNeil E; Goldwein JW Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):143-6. PubMed ID: 9747831 [TBL] [Abstract][Full Text] [Related]
8. Medulloblastoma: time-dose relationship based on a 30-year review. del Charco JO; Bolek TW; McCollough WM; Maria BL; Kedar A; Braylan RC; Mickle JP; Buatti JM; Mendenhall NP; Marcus RB Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):147-54. PubMed ID: 9747832 [TBL] [Abstract][Full Text] [Related]
9. Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival. Hughes EN; Shillito J; Sallan SE; Loeffler JS; Cassady JR; Tarbell NJ Cancer; 1988 May; 61(10):1992-8. PubMed ID: 3129177 [TBL] [Abstract][Full Text] [Related]
10. Treatment results for 149 medulloblastoma patients from one institution. Khafaga Y; Kandil AE; Jamshed A; Hassounah M; DeVol E; Gray AJ Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):501-6. PubMed ID: 8655373 [TBL] [Abstract][Full Text] [Related]
11. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma. Polkinghorn WR; Dunkel IJ; Souweidane MM; Khakoo Y; Lyden DC; Gilheeney SW; Becher OJ; Budnick AS; Wolden SL Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e15-20. PubMed ID: 21481547 [TBL] [Abstract][Full Text] [Related]
12. Reduced-volume tumor-bed boost is not associated with inferior local control and survival outcomes in high-risk medulloblastoma. Tian S; Sudmeier LJ; Zhang C; Madden NA; Buchwald ZS; Shu HG; Curran WJ; Eaton BR; Esiashvili N Pediatr Blood Cancer; 2020 Jan; 67(1):e28027. PubMed ID: 31571408 [TBL] [Abstract][Full Text] [Related]
13. Importance of radiation time and dose factors on outcome for childhood medulloblastoma. Back M; Ahern V; Berry M; Borg M; Sexton M; Cameron F; Stevens G; Allison R; Childs J; Barton M Australas Radiol; 2005 Aug; 49(4):298-303. PubMed ID: 16026436 [TBL] [Abstract][Full Text] [Related]
14. An audit of craniospinal irradiation for medulloblastoma in Newcastle 1970-1992. Tinkler D; Lucraft HH Clin Oncol (R Coll Radiol); 1995; 7(3):179-83. PubMed ID: 7547521 [TBL] [Abstract][Full Text] [Related]
15. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma. Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566 [TBL] [Abstract][Full Text] [Related]
16. Is there an increased risk of spinal relapse in standard-risk medulloblastoma/primitive neuroectodermal tumor patients who receive only a reduced dose of craniospinal radiotherapy? Burcu A; Nazan Ç; Özgür Ö; Serra K; Mehmet K; Serap A; Bengü D; Canan V; Haldun Ö; Savaş K; Tuncer T; Taner A; Yeşim E; Ömer K; Yavuz A Childs Nerv Syst; 2018 Sep; 34(9):1657-1662. PubMed ID: 29868932 [TBL] [Abstract][Full Text] [Related]
17. Radiation treatment for medulloblastoma: a review of 64 cases at a single institute. Liu Y; Zhu Y; Gao L; Xu G; Yi J; Liu X; Li Y Jpn J Clin Oncol; 2005 Mar; 35(3):111-5. PubMed ID: 15741299 [TBL] [Abstract][Full Text] [Related]
18. Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study. Oyharcabal-Bourden V; Kalifa C; Gentet JC; Frappaz D; Edan C; Chastagner P; Sariban E; Pagnier A; Babin A; Pichon F; Neuenschwander S; Vinchon M; Bours D; Mosseri V; Le Gales C; Ruchoux M; Carrie C; Doz F J Clin Oncol; 2005 Jul; 23(21):4726-34. PubMed ID: 16034048 [TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma in adults: treatment results and prognostic factors. Abacioglu U; Uzel O; Sengoz M; Turkan S; Ober A Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):855-60. PubMed ID: 12377339 [TBL] [Abstract][Full Text] [Related]
20. Pattern of recurrence of medulloblastoma after low-dose craniospinal radiotherapy. Wara WM; Le QT; Sneed PK; Larson DA; Prados MD; Levin VA; Edwards MS; Weil MD Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):551-6. PubMed ID: 7928485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]